Home › Immunology › Preparation and Use of HIV-1 Infected Primary CD4+ T-Cells as Target Cells in Natural Killer Cell Cytotoxic Assays
Immunology JoVE (Open Access) Citable · DOI

Preparation and Use of HIV-1 Infected Primary CD4+ T-Cells as Target Cells in Natural Killer Cell Cytotoxic Assays

DOI: 10.3791/2668-v
What you'll learn
  • ✓ Infect primary CD4+ T-cells with HIV-1
  • ✓ Purify infected cells via CD4 down-modulation
  • ✓ Measure NK degranulation by CD107a assay
  • ✓ Quantify NK cytotoxicity by 51Cr release
Protocol

Biopharma Insights Cytotoxicity assays to measure natural killer cell lytic responses to HIV-infected cells is limited by the purity of the target cells. We demonstrate here the isolation of a highly purified population of HIV-1 infected primary T-cell blasts by taking advantage of HIV-1 s ability to down-modulate CD4.

Difficulty
advanced
Total time
~2 weeks (culture and infection) plus 1 day for assays
Model organism
Human primary CD4+ T-cells and HIV-1
Biosafety
BSL-2

Steps

1
Infect CD4+ T-cells with HIV-1

Infect isolated primary CD4+ T-cell blasts with HIV-1 and culture to allow viral replication and CD4 down-modulation.

▶ 01:14
2
Purify HIV-1 infected cells

Exploit HIV-1-induced CD4 down-modulation to isolate a highly pure population of infected cells.

▶ 02:42
3
Perform CD107a degranulation assay

Co-culture NK cells with infected targets and measure CD107a surface expression as a degranulation marker.

▶ 03:41
4
Perform 51Cr release assay

Label target cells with 51Cr and quantify NK cell-mediated cytotoxicity by chromium release.

▶ 06:41
5
Evaluate degranulation and cytotoxicity

Analyze CD107a expression and 51Cr release data to assess NK cell lytic responses.

▶ 10:07
6
Review conclusions

Summarize the utility of purified HIV-1 infected primary T-cells as targets in NK cytotoxic assays.

▶ 11:45
💬 Comments coming soon